On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
about
Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphismInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.Polycystic ovary syndrome: an endocrine and metabolic disease.Racial differences in the association between sex hormone-binding globulin and adiposity in premenopausal women: the BioCycle study.Toward a unifying hypothesis of metabolic syndrome.Medical care from childhood to adulthood in type 1 and type 2 diabetes.Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.Advances in the treatment of polycystic ovary syndrome.Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.Polycystic ovary syndrome in the pediatric populationEffect of testosterone and endurance training on glycogen metabolism in skeletal muscle of chronic hyperglycaemic female rats.Reproductive tissues maintain insulin sensitivity in diet-induced obesity.Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome.Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats.Polycystic ovary syndrome, obesity and reproductive implications.Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary SyndromeIn women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation.Treatment of androgen excess in females: yesterday, today and tomorrow.The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?Reduction of endogenous, ovarian and adrenal androgens with ketoconazole does not alter insulin response in the polycystic ovary syndrome.No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours.Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.Inositolphosphoglycans (IPGs) as mediators of insulin's steroidogenic actions.Serum prostate-specific antigen concentration is increased in acromegalic women.Circulating concentrations of hemostatic factors and two "steroid sensitive proteins" during oral hormone replacement therapy in women with coronary heart disease.Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome.Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.Elective ovarian removal and estrogen replacement therapy--effects on sexual life, psychological well-being and androgen status.Reduction of insulin resistance after correction of nonneoplastic ovarian virilization.The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.Octreotide effect on ovarian morphology in insulin-resistant PCOS patients following six-month decapeptyl treatment.
P2860
Q33239296-540ABB5D-A243-486F-AF00-3BDD05E6234EQ33569169-DE1490C4-F603-444F-B652-563D3D908483Q33923490-50FC3C55-E16B-4F09-9A02-05630F88BE07Q34100589-06C1825E-59D5-4252-91DA-BC207CEDCFE2Q34153563-8E3935FE-CEB4-4490-B033-7669BDB8CF51Q34255878-633E6630-5364-4828-98C1-D27215360045Q34444323-1EF37F9F-8EEB-4966-BDAC-CBE1517BE789Q34451719-1F7203A3-BFD7-40C8-96DF-41852F7BD39FQ34481686-84B385DA-CDE1-49EB-BE44-6DE81F88DAACQ34607225-DD798A67-315D-427F-83FB-68E134616E13Q35075035-20126DEF-DB76-4EDC-A9A1-4F6EF9ED65DCQ35326635-0B20A34D-1319-4C3C-B292-C5F4BD8CCAD6Q35612399-5DB0E875-6220-4876-9273-3E95FF84C987Q36263860-9FB8EC9C-DCBA-4FBE-B950-ED80DBBFDE3BQ37376912-13C80170-2693-4DA4-9EEC-D0983D68640AQ37585306-B8FFBD1E-14AD-43F3-9169-5975C1CC6EBFQ37670397-ACB10E84-7886-4BF4-BEC1-EAF36089D341Q39727044-D456A62C-A6D8-4CC3-AD8F-F0CB5709BF9EQ40869010-AB73EB27-1B31-4095-9C31-B22D96CFB969Q42476937-1C7CCC1E-5771-40F0-89B2-F4051BCEDE92Q42481258-AAD57A36-0F7F-4FD7-8F70-B3683F0646E1Q42488373-4E3D3D22-7315-4D7E-8161-5F0989DBBF02Q42489607-C3E4451A-7D41-4506-8DCA-5C0D72059BCEQ44402842-DE5934CB-4C8C-4218-9B8D-E9E1E5B15D39Q44639847-54308883-FAA1-4EB4-9AEA-F3003C5451CDQ44695733-734D15C6-E295-4B49-8F17-949E0289CA37Q44859933-8DF7220E-A78E-46C4-AE93-BBF8D6A7B9E8Q45125374-4F9144D0-06B2-4262-9E61-62DF5AE6D5B0Q45129497-66BB9936-89D8-44F1-AEBC-681B1227B702Q45254916-1CBD7596-52AE-4B49-977A-F1CB06FC0117Q46218747-DC779A60-7919-4EB5-BF06-67213762E6A8Q46426588-F8FA9B43-5096-4A59-93DB-8ED6B6EB20CAQ51138830-206EC740-9CED-4F29-9DD0-F2E42F4700EFQ51601032-14C82031-C0A5-4B6F-87DE-C3CCF7663F81Q51608740-08FD67A5-0828-45DF-A946-C06E0CFC69F6Q54213056-F3A253AF-32F9-46B2-BFEF-C947B3623A24
P2860
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@en
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@nl
type
label
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@en
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@nl
prefLabel
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@en
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@nl
P356
P1433
P1476
On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.
@en
P2093
Poretsky L
P356
10.1210/EDRV-12-1-3
P577
1991-02-01T00:00:00Z